Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-Ling Chi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam|February 24, 2016
The Score Model Containing Chinese Medicine Syndrome Element of Blood Stasis Presented a Better Performance Compared to APRI and FIB-4 in Diagnosing Advanced Fibrosis in Patients with Chronic Hepatitis BXiao-Ling Chi, Mei-Jie Shi, Huan-Ming Xiao, et al.
World Journal of Hepatology|January 2, 2026
He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation <i>in vivo</i> and <i>in vitro</i>Fo-Lai Zeng, Mei-Jie Shi, You-Sheng Mo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 9, 2022
Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B-A Retrospective Cohort StudyQing-Xia Wang, Jiao Xue, Mei-Jie Shi, et al.
Cancer Management and Research|July 21, 2022
Impact of Metabolic Dysfunction Associated Fatty Liver Disease on the Prognosis of Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Based on Propensity Score Matching AnalysisJiao Xue, Qing-Xia Wang, Huan-Ming Xiao, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 2, 2009
[Evaluation of Chai Shao Liu Jun Tang for the treatment of chronic hepatitis B]Xiao-ling Chi, Li-ming Wu, Jun-min Jiang, et al.
BMC Complementary and Alternative Medicine|December 8, 2016
Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patientsXiao-Ling Chi, Huan-Ming Xiao, Yu-Bao Xie, et al.
Hepatobiliary Surgery and Nutrition|April 25, 2022
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation studyZhong-Wei Chen, Huan-Ming Xiao, Xinjian Ye, et al.
Bioscience Reports|August 25, 2018
<i>XPG</i> rs873601 G>A contributes to uterine leiomyoma susceptibility in a Southern Chinese populationZhi-Qin Liu, Guan-Ge Chen, Ru-Liang Sun, et al.
World Journal of Gastroenterology|March 25, 2020
Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virusXi Cao, Qing-Hua Shang, Xiao-Ling Chi, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 12, 2020
Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine SyndromesMei-Jie Shi, Huan-Ming Xiao, Yu-Bao Xie, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Evidence-Based Complementary and Alternative Medicine : Ecam|February 24, 2016
The Score Model Containing Chinese Medicine Syndrome Element of Blood Stasis Presented a Better Performance Compared to APRI and FIB-4 in Diagnosing Advanced Fibrosis in Patients with Chronic Hepatitis BXiao-Ling Chi, Mei-Jie Shi, Huan-Ming Xiao, et al.
World Journal of Hepatology|January 2, 2026
He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation <i>in vivo</i> and <i>in vitro</i>Fo-Lai Zeng, Mei-Jie Shi, You-Sheng Mo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 9, 2022
Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B-A Retrospective Cohort StudyQing-Xia Wang, Jiao Xue, Mei-Jie Shi, et al.
Cancer Management and Research|July 21, 2022
Impact of Metabolic Dysfunction Associated Fatty Liver Disease on the Prognosis of Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Based on Propensity Score Matching AnalysisJiao Xue, Qing-Xia Wang, Huan-Ming Xiao, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 2, 2009
[Evaluation of Chai Shao Liu Jun Tang for the treatment of chronic hepatitis B]Xiao-ling Chi, Li-ming Wu, Jun-min Jiang, et al.
BMC Complementary and Alternative Medicine|December 8, 2016
Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patientsXiao-Ling Chi, Huan-Ming Xiao, Yu-Bao Xie, et al.
Hepatobiliary Surgery and Nutrition|April 25, 2022
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation studyZhong-Wei Chen, Huan-Ming Xiao, Xinjian Ye, et al.
Bioscience Reports|August 25, 2018
<i>XPG</i> rs873601 G>A contributes to uterine leiomyoma susceptibility in a Southern Chinese populationZhi-Qin Liu, Guan-Ge Chen, Ru-Liang Sun, et al.
World Journal of Gastroenterology|March 25, 2020
Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virusXi Cao, Qing-Hua Shang, Xiao-Ling Chi, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 12, 2020
Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine SyndromesMei-Jie Shi, Huan-Ming Xiao, Yu-Bao Xie, et al.
Pageof 2